BlackRock’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$98 Hold
9
﹤0.01% 5614
2026
Q1
$340 Hold
9
﹤0.01% 5584
2025
Q4
$329 Hold
9
﹤0.01% 5446
2025
Q3
$1.59K Hold
9
﹤0.01% 5331
2025
Q2
$2.16K Hold
9
﹤0.01% 5318
2025
Q1
$2.33K Hold
9
﹤0.01% 5294
2024
Q4
$8.08K Hold
9
﹤0.01% 5184
2024
Q3
$3.43K Sell
9
-1
-10% -$1.24K ﹤0.01% 5075
2024
Q2
$21.5K Hold
10
﹤0.01% 5004
2024
Q1
$34K Hold
10
﹤0.01% 4945
2023
Q4
$105K Hold
10
﹤0.01% 4788
2023
Q3
$180K Hold
10
﹤0.01% 4710
2023
Q2
$433K Sell
10
-3
-23% -$112K ﹤0.01% 4523
2023
Q1
$517K Hold
13
﹤0.01% 4520
2022
Q4
$819K Hold
13
﹤0.01% 4466
2022
Q3
$795K Hold
13
﹤0.01% 4564
2022
Q2
$803K Hold
13
﹤0.01% 4618
2022
Q1
$1.31M Hold
13
﹤0.01% 4566
2021
Q4
$758K Buy
13
+1
+8% +$83.4K ﹤0.01% 4752
2021
Q3
$1.45M Hold
12
﹤0.01% 4445
2021
Q2
$1.84M Sell
12
-33
-73% -$5.41M ﹤0.01% 4307
2021
Q1
$8.62M Hold
45
﹤0.01% 3666
2020
Q4
$8.16M Buy
45
+2
+5% +$309K ﹤0.01% 3478
2020
Q3
$6.41M Buy
43
+1
+2% +$158K ﹤0.01% 3469
2020
Q2
$5.74M Buy
+42
New +$5.13M ﹤0.01% 3467
2019
Q2
Hold
0
-$26K 5036
2019
Q1
Hold
0
4563
2018
Q4
Hold
0
4586
2018
Q3
Hold
0
4753
2018
Q2
Hold
0
4628

Other funds holding GNPX

BlackRock's GNPX Position: Q2 2026 in Review

BlackRock held its Genprex (GNPX) position steady in Q2 2026 at 9 shares worth $98. The position accounts for ﹤0.01% of the portfolio, ranked #5614.

BlackRock first reported a position in GNPX in Q2 2020 and has held it in 25 quarters since. The position peaked at $8.62M in Q1 2021. 11 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.

  • BlackRock held 9 shares of Genprex worth $98 as of Q2 2026.
  • BlackRock left its Genprex share count unchanged in Q2 2026.
  • Genprex made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5614 holding.
  • BlackRock first reported a position in Genprex in Q2 2020 and has held it in 25 quarters since.
  • BlackRock's Genprex position peaked at $8.62M in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Genprex as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.